News

LyondellBasell Unveils New Leadership Transition in Finance

LyondellBasell Unveils New Leadership Transition in Finance

LyondellBasell Announces Leadership Change in Finance

LyondellBasell has made a significant announcement regarding its executive leadership. Beginning March 1, 2025, Michael McMurray will retire from his position as executive vice president and chief financial officer. He will be succeeded by Agustin Izquierdo, who currently holds the title of senior vice president for Olefins & Polyolefins Americas and Refining. Until his official transition, Izquierdo will continue to fulfill his present duties.

Acknowledging Contributions and Leadership

Peter Vanacker, the CEO of LyondellBasell, expressed deep gratitude for McMurray's contributions over the past five years. "Michael has been a key player in shaping our strategy and enhancing our financial performance. His leadership has been pivotal in transforming our finance department, ensuring we meet the needs of a dynamic market," said Vanacker. He also commended the company for promoting internal talent, emphasizing that Izquierdo’s extensive experience will be invaluable in navigating future challenges.

Agustin Izquierdo’s Path to CFO

Izquierdo joined LyondellBasell in November 2022 as the vice president for Strategy & Finance, Intermediates & Derivatives. Before that, he spent over a decade at BASF in various high-level roles, culminating in his tenure as vice president of Planning, Finance, and Digital. This background equips him with a unique perspective that he plans to leverage in his new role.

Looking Ahead: Strategic Goals

Excitement surrounds Agustin's future at LyondellBasell. In his own words, "I'm eager to step into the CFO role and collaborate with our talented team to drive performance. Since my arrival in 2022, we have made significant headway in our strategic initiatives. I aim to build upon Michael's achievements and our robust financial foundation to propel us forward." His enthusiasm reflects a commitment to maintaining the momentum gained under McMurray's guidance.

A Fond Farewell from McMurray

Reflecting on his time, McMurray stated, "Serving as CFO at LyondellBasell has been a tremendous honor. I sincerely thank my colleagues and the Board for their unwavering support as we tackled numerous challenges and seized opportunities that strengthened LYB's financial standing. I am confident in the company's future." His sentiments resonate with the collective appreciation for his leadership during transformative times.

About LyondellBasell

LyondellBasell is a global leader in the chemical industry, committed to creating sustainable solutions for everyday life. Through cutting-edge technology and focused investments, the company strives to enable a circular economy with lower carbon emissions. As one of the world’s largest plastic producers, LyondellBasell addresses key global challenges, providing innovative products ranging from sustainable transportation fuel to improved healthcare solutions.

Company Contact Information

For further inquiries, please contact:
Media Contact: Monica Silva at +1 713-309-4791
Investor Contact: David Kinney at +1 713-309-7141
Nick Facchin, LyondellBasell, at 713-623-3643
Email: nick.facchin@lyondellbasell.com

Frequently Asked Questions

Who is the new CFO of LyondellBasell?

The new CFO will be Agustin Izquierdo, effective March 1, 2025.

What are Michael McMurray's contributions to LyondellBasell?

McMurray has significantly shaped the company's finance strategy and enhanced financial performance during his tenure.

What experience does Agustin Izquierdo have?

Izquierdo has extensive experience, previously working at BASF for over a decade and joining LyondellBasell in 2022.

What is LyondellBasell known for?

LyondellBasell is known for being one of the largest producers of polymers and innovative products that support sustainability.

How can I contact LyondellBasell?

You can reach out for media inquiries or investment contact through provided phone numbers and email addresses.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 86

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 149

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 210

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 181

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 31

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 67

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 24

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 207

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 51

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 37

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Challenge: Investors Pursue Justice Against TLX

Updated Category News Views 164

Opportunity for Investors in Telix Pharmaceuticals Ltd. Attention, investors! A significant event has unfolded for those who have purchased securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX). The Rosen Law Firm, well-known for representing investors' rights, has initiated a class action lawsuit on behalf of these investors. This development presents a chance for you...

Continue Reading
Turvo and SMC3 Forge Alliance to Enhance Freight Efficiency

Updated Category News Views 158

Strategic Partnership Between Turvo and SMC3 Industry leaders are joining forces to enhance freight management solutions, facilitated by insights from a global logistics company. Turvo, known for its collaborative application tailored for the supply chain, has announced an integration partnership with SMC3, a respected provider of less-than-truckload (LTL) freight...

Continue Reading
Fnac Darty Takes Major Steps in Unieuro Acquisition Process

Updated Category News Views 148

Fnac Darty Makes Progress in Unieuro Acquisition Fnac Darty has recently announced significant developments regarding its acquisition of Unieuro. The authorization to officially notify this transaction was granted by the European Commission, following a pre-notification phase that lasted several months. This is an exciting development for shareholders and has set the...

Continue Reading
LOGISTEC Appoints Cleidy Liborio Fernandes as CCO for Growth

Updated Category News Views 202

CLEIDY LIBORIO FERNANDES JOINS LOGISTEC AS CHIEF COMMERCIAL OFFICER LOGISTEC, a prominent provider of marine and environmental services in North America, is delighted to announce the appointment of Cleidy Liborio Fernandes as the new Chief Commercial Officer. Cleidy's extensive background in international business and strategic development is expected to spearhead the...

Continue Reading
IMUNON Inc's Latest Developments Drive Stock Surge Today

Updated Category News Views 233

IMUNON Inc's Stock Surge Explained Shares of IMUNON Inc (NASDAQ: IMNN) are seeing a remarkable uptick in trading this Wednesday. The excitement is largely due to the company achieving a significant clinical milestone for its lead drug candidate, IMNN-001. This news has generated substantial interest among investors and highlights IMUNON's progress in the pharmaceutical...

Continue Reading